General description
An increasing number of pharmaceuticals in human and veterinary medicine are being developed using advanced genetic and other methods that focus on modification of somatic and embryonic cells. These methods call for new processes that go beyond the traditional unit processes of chemical and biological production. This book is the first to describe these advanced biological processes and show how they are applied to the production of biopharmaceuticals, from product generation and purification to fill-finish operations. The work explains how these technologies function similarly to unit operations for producing advanced biopharmaceuticals, such as hormones, modified proteins, etc. From large-scale animal cell bioreactors to patient-customized products, this volume guides users on how to apply new technologies in process development.